TAIPEI, Taiwan--(BUSINESS WIRE)--QPS, a leading global contract research organization (CRO) specializing in preclinical and clinical drug development services, is pleased to announce the expansion of ...

U ntil recently, no treatments were available to help slow the progression of metabolic dysfunction–associated steatohepatitis (MASH), a severe form of fatty liver disease. But in March 2024, a ...

Analysis of liver sinusoidal endothelial cells (“LSEC”) from screening and end of treatment biopsies in the Phase 2b NATIVE study showed evidence of LSEC capillarization in patients without MASH, and ...

Macrophages are the first line of defense of the immune system, helping fight infections and keeping tissues healthy. But in the context of some chronic diseases, these immune cells undergo changes ...